BOLA2-SMG1P6 readthrough (BOLA2-SMG1P6)

The **BOLA2-SMG1P6 readthrough** gene represents a naturally occurring transcriptional readthrough event between the upstream **BOLA2 (BolA family member 2)** gene and the downstream **SMG1 pseudogene 6 (SMG1P6)** locus[1][3]. This produces fusion transcripts, some of which may encode protein products with an N-terminal domain similar to BOLA2 and a C-terminal region related to SMG1 phosphatidylinositol 3-kinase-related kinase[1][4]. The biological significance, function, and disease relevance of this readthrough fusion are not established. Most molecular and disease associations in current literature describe BOLA2 separately, as a protein involved in iron-sulfur cluster assembly and cytosolic iron homeostasis, but there is no evidence that the BOLA2-SMG1P6 readthrough is itself a therapeutic drug target, receptor, enzyme, or otherwise actionable molecule[1][2][4]. **Note:** This entry describes a readthrough/fusion transcript, **not a classical receptor, enzyme, transporter, or therapeutic target**. No established function, disease relevance, or drug interactions are attributed to the BOLA2-SMG1P6 readthrough itself, and most available data describe the parent gene, BOLA2[1][2][4]. Thus, it is not recognized as a druggable target or canonical molecular entity for therapeutic modulation.

Other names

BOLA2-SMG1P6 readthrough

None known